Korean Diabetes J.  2008 Jun;32(3):290-291. 10.4093/kdj.2008.32.3.290.

The Biochemical Markers of Coronary Heart Disease Correlates Better to Metabolic Syndrome Defined by WHO than by NCEP-ATP III or IDF in Korean Type 2 Diabetic Patients

• Kim BJ

• KMID: 2298100
• DOI: http://doi.org/10.4093/kdj.2008.32.3.290

Abstract

No abstract available.

MeSH Terms

Biomarkers
Coronary Disease
Humans

Reference

1. Lorenzo C, Williams K, Hunt KJ, Haffner SM. The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care. 2007. 30:8–13.

2. Tong PC, Kong AP, So WY, Yang X, Ho CS, Ma RC, Ozaki R, Chow CC, Lam CW, Chan JC, Cockram CS. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes. Diabetes Care. 2007. 30:1206–1211.

3. Koehler C, Ott P, Benke I. Hanefeld M DIG Study Group. Comparison of the prevalence of the metabolic syndrome by WHO, AHA/NHLBI, and IDF definitions in a German population with type 2 diabetes: the Diabetes in Germany (DIG) Study. Horm Metab Res. 2007. 39:632–635.

4. Wannamethee SG. The metabolic syndrome and cardiovascular risk in the British Regional Heart Study. Int J Obes. 2008. 32:Suppl 2. S25–S28.